AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Feb 28, 2014

3377_rpt_2014-02-28_793bf029-d9d8-4e57-ae82-5273137352e1.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

February 28, 2014

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

Name Jørgen Buhl Rasmussen
Relation/category of close relation Board Member
Trading date 28.02.2014
Market Nasdaq OMX Copenhagen A/S
Character of transaction Buy of shares
Volume of transaction buy(+)/ sell (-) +2,000
Value of transaction (DKK) 505,113.00 DKK
Contact information
Investor Relations:
Thomas Bomhoff (DK) +45 3077 1226 [email protected]
Klaus Sindahl (DK) +45 5363 0134 [email protected]
Martin Riise (USA) +1 919 649 2565 [email protected]
Press and media:
Rene Tronborg (DK) +45 3077 2274 [email protected]
Frederik Bjoerndal (Europe) +45 3077 0236 [email protected]
Paige Donnelly (USA) +1 919 218 4501 [email protected]
Meng Lian (China) +86 136 9923 1164 [email protected]
Henrique Pellini (Brazil) +55 41 9288 0282 [email protected]
Poonam Kapila (India) +91 991 082 2339 [email protected]

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Krogshoejvej 36 2880 Bagsvaerd Denmark

Telephone: +45 4446 0000 Email: [email protected] Internet: www.novozymes.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.